ADACEL-POLIO susp inj s aiguille 10 ser pré 0.5 ml

7680681100065 CH-68110 J07CA02 08.08.
ADACEL-POLIO susp inj s aiguille 10 ser pré 0.5 ml
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6811001
CPT
-
Packaging group
10 x 0.5 ml
Unit
Fertigspritze(n)
Composition
toxoidum diphtheriae min. 2 U.I., toxoidum tetani min. 20 U.I., toxoidum pertussis 2.5 µg, haemagglutininum filamentosum 5 µg, pertactinum 3 µg, fimbriae types 2 et 3 5 µg, virus poliomyelitis typus 1 inactivatus 29 U., virus poliomyelitis typus 2 inactivatus 7 U., virus poliomyelitis typus 3 inactivatus 26 U., aluminii phosphas corresp. aluminium 0.33 mg, phenoxyethanolum, ethanolum 1.01 mg, polysorbatum 80, aqua ad iniectabile, ad suspensionem pro 0.5 ml corresp. ethanolum 0.3 % V/V, residui: formaldehydum, glutaralum, streptomycinum, neomycinum, polymyxinum B, albuminum seri bovis.

Articles (1)

Adacel-Polio 0.5 ml, suspension injectable en seringue préremplie
suspension
10 x 0.5 ml
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
15/02/2024
Professional SmPC
Français
15/02/2024
Professional SmPC
Italien
15/02/2024

Detailed composition

Substance Quantity Type Category
toxoidum diphtheriae
- Substance Wirkstoff (Principe actif)
toxoidum tetani
- Substance Wirkstoff (Principe actif)
toxoidum pertussis
2.5 UG Substance Wirkstoff (Principe actif)
haemagglutininum filamentosum
5.0 UG Substance Wirkstoff (Principe actif)
pertactinum
3.0 UG Substance Wirkstoff (Principe actif)
fimbriae
5.0 UG Substance Wirkstoff (Principe actif)
virus poliomyelitis typus 1 inactivatus
29.0 U Substance Wirkstoff (Principe actif)
virus poliomyelitis typus 2 inactivatus
7.0 U Substance Wirkstoff (Principe actif)
virus poliomyelitis typus 3 inactivatus
26.0 U Substance Wirkstoff (Principe actif)
aluminii phosphas
- Substance HNIDK
aluminium
0.33 MG Substance HNIDK
phenoxyethanolum
- Substance Konservierungsstoff (Conservateur)
ethanolum
1.01 MG Substance HBESI
polysorbatum 80
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
formaldehydum
- Substance RESI
glutaralum
- Substance RESI
streptomycinum
- Substance RESI
neomycinum
- Substance RESI
polymyxinum B
- Substance RESI
albuminum seri bovis
- Substance RESI

Authorization holder

Sanofi-Aventis (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
68110
Drug name
Adacel-Polio, suspension injectable en seringue préremplie
Galenic form
INJFS
ATC Code
J07CA02
Authorization status
Z
Dispensation category
B
First authorization
26/08/2022
Authorization expiration date
25/08/2027
IT number
08.08.
Domain
Human medicine

Packaging details

Description (FR)
ADACEL-POLIO susp inj s aiguille 10 ser pré 0.5 ml
Description (DE)
ADACEL-POLIO Inj Susp o Nadel 10 Fertspr 0.5 ml
Market launch
26/08/2022
Narcotic (BTM)
No

Other packaging sizes

ADACEL-POLIO susp inj a aiguille ser pré 0.5 ml
1 x 0.5 ml FESP
View
Buy us a coffee Explore the data